The surprisingly large and irregular practices of the private tuberculosis (TB) drug market could be driving treatment failures and the emergence of multi-drug resistance (MDR), according to a new report in the journal PLoS ONE. The study found the private TB drug market is now just as big as the public market, whereas previously TB […]
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an […]
Research & Development
While the committee examining the Ebola epidemic in the Democratic Republic of Congo emerged today from its 5th meeting with the conclusion that transmissions of the […]
Policy
DRC, Liberia, Madagascar, Somalia and Ukraine account for nearly half of global measles cases Measles incidence increased in five regions around the world between 2016 and […]